Silverstein Foundation Annual Update

Vanqua Bio closes $85 million Series B financing

Silverstein Foundation Announces Grant Funding to AcureX Therapeutics.

Prevail Announces First Patient Dosed

Prevail Therapeutics Acquired by Lilly

Aspen Neuroscience Announces $70 Million Series A Financing